Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year.Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million.Full-year 2025 ...

Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...

Patent Bots, creator of AI-enabled software for patent attorneys, today announced the launch of its newest product, ...

The US ITC has released an initial determination that says Insta360's cameras infringe on some of GoPro's patents.

The patent for SkinCeuticals' pricey C E Ferulic serum expired. Skincare industry experts told BI what it would take to get cheaper dupes in the mix.

If you are a patent holder and are selling a product covered by your patent, please remember to mark your products. The purpose of patent marking is ...

The Patent Act requires patentees to mark their products with the numbers of any patents that cover that product. Put differently, if you produce a ...

Inhalers are the mainstay of treatment for asthma and chronic obstructive pulmonary disease (COPD). These products face limited generic competition in the US and remain expensive. To better ...

By adding this old technology to its insulin drug, Glargine, however, the pharmaceutical giant Sanofi was nonetheless able to secure additional patents for a lucrative product.

Drug–device combination products are becoming increasingly prevalent, with many lasting years beyond the expiration date of primary and secondary patents on the drug itself.

The international patent exhaustion holding is particularly troubling, says Bob Stoll. Companies will not be able to lower prices to sell products abroad.

Today’s consumer products companies have a wealth of competitive issues to face in managing their businesses in a global economy. Given these challenges, it is not surprising that addressing issues ...